OSIRIS THERAPEUTICS, INC.·4

Dec 10, 7:54 AM ET

FRIEDLI PETER 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Dec 10, 2012

Insider Transaction Report

Form 4
Period: 2012-12-10
FRIEDLI PETER
Director10% OwnerOther
Transactions
  • Sale

    Common Stock

    2012-12-10$9.52/sh50,000$476,0004,606,051 total(indirect: See Note 2)
Holdings
  • Common Stock

    9,616,794
Footnotes (2)
  • [F1]Represents the sale by Venturetec, Inc. of 50,000 shares of common stock in a private transaction to a corporation formed under the laws of Belize at the price of USD $9.52 per share, which represents the average trading price of the shares over the past thirty trading days.
  • [F2]The Reporting Person holds indirect beneficial ownership of 4,103,301 shares of common stock held by Venturetec, Inc., 500,000 shares held by his minor daughter and 2,750 shares held by his spouse. The Reporting Person holds approximately a 3% interest in Venturetec, Inc. and serves as its president. The Reporting Person disclaims beneficial ownership in the shares held by his daughter and spouse and disclaims beneficial interest in the shares held by Venturetec, Inc., beyond the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -